Advertisement

Regarding the survey on perioperative diabetes medications and glucose control

  • M. S. RaghuramanEmail author
Correspondence

Notes

Conflict of interest

None declared.

Editorial responsibility

This submission was handled by Dr. Hilary P. Grocott, Editor-in-Chief, Canadian Journal of Anesthesia.

References

  1. 1.
    Brown R, Siddiqui U, Paul J. A survey: perioperative diabetes medications and glucose control—time to re-examine management? Can J Anesth 2019; 66: 621-2.CrossRefGoogle Scholar
  2. 2.
    Umpierrez GE, Gianchandani R, Smiley D, et al. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study. Diabetes Care 2013; 36: 3430-5.CrossRefGoogle Scholar
  3. 3.
    Pasquel FJ, Gianchandani R, Rubin DJ, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol 2017; 5: 125-33.CrossRefGoogle Scholar
  4. 4.
    Garg R, Schuman B, Hurwitz S, Metzger C, Bhandari S. Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients. BMJ Open Diabetes Res Care 2017; 5: e000394.CrossRefGoogle Scholar
  5. 5.
    Palermo NE, Garg R. Perioperative management of diabetes mellitus: novel approaches. Curr Diab Rep 2019; 19: 14.CrossRefGoogle Scholar

Copyright information

© Canadian Anesthesiologists' Society 2019

Authors and Affiliations

  1. 1.Department of AnesthesiologySri Venkateshwaraa Medical College Hospital and Research CentreAriyurIndia

Personalised recommendations